N-[(2-methyl-1H-indol-3-yl)-(4-methylsulfanylphenyl)methyl]pyridin-2-amine

ID: ALA5189912

PubChem CID: 3447990

Max Phase: Preclinical

Molecular Formula: C22H21N3S

Molecular Weight: 359.50

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CSc1ccc(C(Nc2ccccn2)c2c(C)[nH]c3ccccc23)cc1

Standard InChI:  InChI=1S/C22H21N3S/c1-15-21(18-7-3-4-8-19(18)24-15)22(25-20-9-5-6-14-23-20)16-10-12-17(26-2)13-11-16/h3-14,22,24H,1-2H3,(H,23,25)

Standard InChI Key:  BULDSMXGVHSVEQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.4665    2.0334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1811    2.4457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8930    2.0338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8930    1.2087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1829    0.7969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4665    1.2050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3408    0.9537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8135    1.6101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3195    2.2803    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6387    1.6101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5543    0.1566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0290   -0.4267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3514   -0.0568    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5650   -0.8538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9817   -1.4375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1953   -2.2320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9926   -2.4457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5743   -1.8662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3655   -1.0683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8262   -0.2134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4074   -0.7957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1938   -1.5929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4010   -1.8070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1854   -1.2272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7773   -2.1764    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.5743   -1.9628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  6  7  1  0
  7  8  2  0
  9  8  1  0
  1  9  1  0
  8 10  1  0
  7 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 15 14  2  0
 16 15  1  0
 17 16  2  0
 18 17  1  0
 19 18  2  0
 14 19  1  0
 20 12  2  0
 21 20  1  0
 22 21  2  0
 23 22  1  0
 24 23  2  0
 12 24  1  0
 22 25  1  0
 25 26  1  0
M  END

Associated Targets(Human)

BCL2A1 Tchem Bcl-2-related protein A1 (291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCL2 Tclin Apoptosis regulator Bcl-2 (3787 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCL2L11 Tchem Bcl-2-like protein 11/Bcl-2-related protein A1 (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 359.50Molecular Weight (Monoisotopic): 359.1456AlogP: 5.79#Rotatable Bonds: 5
Polar Surface Area: 40.71Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.52CX LogP: 5.26CX LogD: 5.21
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.44Np Likeness Score: -1.33

References

1. Feng X, Yan Z, Zhou F, Lou J, Lyu X, Ren X, Zeng Z, Liu C, Zhang S, Zhu D, Huang H, Yang J, Zhao Y..  (2022)  Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells.,  236  [PMID:35385805] [10.1016/j.ejmech.2022.114327]
2. Li X, Dou J, You Q, Jiang Z..  (2021)  Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy.,  220  [PMID:34034128] [10.1016/j.ejmech.2021.113539]

Source